Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ROIV · against 86 other Healthcare companies of similar size
Ranked #87 of 87 · scores higher than 0% of peers
Bars: peers in each 10-point band of the growth score1 peers with a growth score of 0–9, including ROIV · Click a bar to see the companies
Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | ROIV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 88 reported | -67.6% | 9.9% | 0% | 33% | |
| Earnings per share growthHigher is better · 66 reported | Not reported | 17.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 86 reported | -46.4% | 9.8% | 0% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 21.4B USD | 97 | 67 | |
| 2 | 16.5B USD | 96 | 37 | |
| 2 | 14.5B USD | 96 | 30 | |
| 4 | 22.8B USD | 95 | 38 | |
| 5 | 40.2B USD | 92 | 73 | |
| 83 | 36.8B USD | 20 | 46 | |
| 84 | 225.2B CNY (≈$31.5B) | 19 | 63 | |
| 85 | 21.8B USD | 18 | 32 | |
| 86 | 15.7B USD | 17 | 33 | |
| 87 | 26.0B USD | 5 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score